Skip to main content
. 2016 Nov 4;8(11):100. doi: 10.3390/cancers8110100

Figure 8.

Figure 8

Validation of protein and mRNA changes in TGF-β signaling within NAFs and CAFs. (A) Western blot analysis of canonical Smad signaling in NAFs and CAFs treated with 200 ng/mL of sTβRIII for 24 h; and (B) qPCR for canonical TGF-β/BMP signaling components and targets.